Research Directory

Biotechs shift priorities amidst financing challenges

Read more

FDA draft guidance on psychedelics

Read more

Commentary: FDA guides industry on psychedelic drugs

Read more

How pharma manages organisational complexity

Read more

European Biopharma doesn't skimp on R&D

Read more

Commentary: The analysis of biopharma R&D needs to be improved

Read more

US selects first drugs for price negotiations

Read more

New system for patents takes effect in EU

Read more

The EMA reviews the use of real-world evidence

Read more

Partnering antisense oligonucleotides

Read more